FrancophonIA/ELRC3.0 huggingface dataset:
English: Consequently, cabergoline administration induces a reduction of milk production leading to a reduction in udder engorgement and intramammary pressure.
Croatian: Posljedično, primjena karbegolina uzrokuje smanjenje proizvodnje mlijeka i dovodi do smanjenja nabreklosti vimena i intramamarnog pritiska.
English: The administration of three or five times the recommended dose for 3 consecutive days (i.e. corresponding to 9 and 15 times the recommended dose, respectively) resulted in addition in some cases in transient and reversible digestive signs such as diarrhoea.
Croatian: Primjena doza tri ili pet puta većih od preporučene tijekom 3 uzastopna dana (odgovara 9 odnosno 15 puta većim dozama od preporučene) u nekim je slučajevima dovelo i do prolaznih i reverzibilnih probavnih znakova kao što je proljev.
English: For use in the herd management programme of dairy cows as an aid in the abrupt drying-off by reducing milk production to: - reduce milk leakage at drying off, - reduce the risk of new intramammary infections during the dry period, - reduce discomfort.
Croatian: Za primjenu u planiranom upravljanju stadom muznih krava kao pomoć pri naglom zasušivanju smanjivanjem lučenja mlijeka kako bi se: - smanjilo curenje mlijeka tijekom isušivanja, - smanjio rizik novih intramamarnih infekcija tijekom suhostaja, - smanjila nelagoda.
English: For the 25 ml, 50 ml and the 5x5ml only: Once broached, use within 28 days.
Croatian: Samo za pakovanja od 25 ml, 50 ml i 5x5ml: Nakon otvaranja, upotrijebite unutar 28 dana.
English: Cabergoline is a synthetic ergot derivative, which is a potent dopamine receptor agonist on D2 receptors.
Croatian: Kabergolin je sintetski derivat ergolina koji je snažan agonist D2 dopaminskih receptora.
English: Overdoses resulted in some cases in slight and transient decrease of appetite.
Croatian: Predoziranje je u nekim slučajevima uzrokovalo blago i prolazno smanjenje apetita.
English: Brown glass vials closed by bromobutyl stoppers and crimped with aluminium and plastic flip capsules.
Croatian: Bočice od smeđeg stakla zatvorene bromobutilnim čepovima obavijenim s aluminijskom kapicomi s plastičnim "flip-off" zatvaračima.
English: Clear pale yellow solution.
Croatian: Bistra blijedo žuta otopina.
English: - 4 days (8 milkings) after calving when the dry period length is less than 32 days
Croatian: - 4 dana (8 mužnji) nakon telenja ako je suhostaj trajao kraće od 32 dana.
English: Subsequently udder pain and discomfort are reduced at one and two days after drying off, respectively.
Croatian: Posljedično se bol i nelagoda u vimenu smanjuju tijekom jednog odnosno dva dana nakon zasušivanja.
English: After intramuscular administration in cattle, the systemic absorption of cabergoline is rapid and important (bioavailability over 90%), with a peak concentration observed around 3 h after administration and followed by a high tissue distribution.
Croatian: Nakon intramuskularne primjene u goveda, sistemska apsorpcija kabergolina je brza i značajna (biodostupnost preko 90%), s vršnom koncentracijom uočenom otprilike 3 sata nakon primjene popraćenom visokim stupnjem tkivne distribucije.
English: The cows should be diagnosed to be free of subclinical mastitis by using suitable criteria such as bacterial examination of milk, somatic cell count or other recognized tests.
Croatian: Odsutnost subkliničkog mastitisa u krava treba potvrditi prema odgovarajućim kriterijima kao što su bakteriološki pregled mlijeka, broj somatskih stanica ili drugi priznati testovi.
English: The veterinary medicinal product may cause skin sensitisation and persons with a known hypersensitivity to cabergoline or any of the excipients should avoid contact with it.
Croatian: Veterinarsko-medicnski proizvod može uzrokovati senzibilizaciju kože i osobe preosjetljive na kabergolin ili bilo koju od pomoćnih tvari trebaju izbjegavati kontakt s njim.
English: In vitro, some macrolide antibiotics, like erythromycin, inhibited the activity of bovine Cytochrom P 450-enzymes (CYP3A4-subclass).
Croatian: In vitro su neki makrolidni antibiotici, kao eritromicin, inhibirali aktivnost goveđih enzima citokroma P450 (podvrsta CYP3A4).
English: Velactis should be used as part of a comprehensive mastitis and milk quality control program under veterinarian advice, which might include the need to use intramammary treatment.
Croatian: Velactis treba koristiti kao dio sveobuhvatnog programa kontrole mastitisa i kvalitete mlijeka što može uključivati i potrebu intramamarne terapije pod nadzorom veterinara.
English: The product should be administered within 4 hours after the last milking.
Croatian: Proizvod treba primijeniti unutar 4 sata nakon zadnje mužnje.
English: QUANTITY OF THE ACTIVE SUBSTANCE(S) 1.12 mg/ml
Croatian: KOLIČINA DJELATNE(IH) TVARI 1,12 mg/ml
English: Pregnant or breastfeeding women and women attempting to conceive should avoid contact with the solution and should be prevented from an accidental self-injection.
Croatian: Trudnice ili žene koje doje te žene koje pokušavaju začeti trebaju izbjegavati kontakt s otopinom i spriječiti slučajno samoinjiciranje.
English: Cardboard box with 1 vial of 5 ml, 25 ml or 50 ml, or 5 vials of 5 ml.
Croatian: Kartonska kutija s jednom bočicom od 5 ml, 25 ml ili 50 ml; ili 5 bočica od 5 ml.
English: Milk: - zero hours after calving when the dry period length is 32 days or more.
Croatian: Mlijeko: - nula sati nakon telenja ako je suhostaj trajao 32 dana ili dulje.
English: Cabergoline should not enter surface waters as it has harmful effects on aquatic species.
Croatian: Kabergolin ne smije dospjeti u površinske vode jer štetno djeluje na vodene organizme.
English: Persons with a known hypersensitivity to cabergoline or any of the excipients should avoid contact with the veterinary medicinal product.
Croatian: Osobe preosjetljive na kabergolin ili na bilo koju od pomoćnih tvari trebaju izbjegavati kontakt s veterinarsko-medicinskim proizvodom.
English: The recommended dose is 5.6 mg of cabergoline (corresponding to 5 ml of solution for injection) per animal in one single injection at the day of drying-off after the last milking.
Croatian: Preporučena doza je 5,6 mg kabergolina (odgovara 5 ml otopine za injekciju) po životinji u jednoj jednokratnoj injekciji na dan zasušivanja nakon zadnje mužnje.
English: The difference between groups was 13.7% (95% confidence interval 6.4-21%).
Croatian: Razlika između skupina bila je 13,7% (95% interval pouzdanosti; 6,4-21%).
English: It acts on dopamine receptors of prolactin producing cells in the pituitary gland suppressing the prolactin production and leading to the inhibition of prolactin secretion dependent process.
Croatian: Djeluje na dopaminske receptore stanica koje proizvode prolaktin u hipofizi suprimirajući proizvodnju prolaktina i dovodeći do inhibicije procesa ovisnih o lučenju prolaktina.
English: In a multicentric randomized clinical trial where dairy cows with no intramammary infections at the time of drying-off were administered either Velactis or placebo at the time of drying-off, the incidence of new intramammary infections within 7 days after subsequent calving was significantly lower among udder quarters of cows treated with Velactis (20.5%) as compared to placebo (26.0%).
Croatian: U multicentričkom randomiziranom kliničkom ispitivanju u kojem je u muznih krava bez intramamarne infekcije u vrijeme zasušivanja primjenjivan Velactis ili placebo u vrijeme zasušivanja, učestalost novih intramamarnih infekcija unutar 7 dana nakon telenja bila je značajno niža u četvrtima vimena krava liječenih Velactisom (20,5%) u usporedbi s placebom (26,0%).
English: In a randomized and placebo controlled clinical study, reduced discomfort was demonstrated during the first day after drying-off by increasing daily lying time by 143 +/- 17 minutes in Velactis treated animals in comparison with untreated controls.
Croatian: U randomiziranom i placebom kontroliranom kliničkom ispitivanju pokazalo se smanjenje nelagode tijekom prvog dana nakon zasušivanja koje se manifestiralo produženjem vremena ležanja za 143 +/- 17 minuta u životinja liječenih Velactisom u usporedbi s neliječenim životinjama.
English: DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED Detailed information on this product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).
Croatian: Detaljne informacije o ovom veterinarsko-medicinskom proizvodu dostupne su na web stranici Europske agencije za lijekove (http://www.ema.europa.eu/).
English: In a randomized and placebo controlled clinical study Velactis treated cows presented less signs of udder pain in comparison with controls on the first two days after drying-off.
Croatian: U randomiziranom i placebom kontroliranom kliničkom ispitivanju krave liječene Velactisom pokazivale su manje znakova boli u vimenu u usporedbi s kontrolama u prva dva dana nakon zasušivanja.
English: At 9 times the recommended dose a decrease in ruminal activity may be observed.
Croatian: Pri dozama 9 puta većima od preporučene može se uočiti smanjeno preživanje.
English: In the same study, incidence of milk leakage was significantly lower among Velactis treated animals (2.0%) as compared to placebo treated animals (10.7%).
Croatian: U istom ispitivanju učestalost curenja mlijeka bila je značajno niža u životinja liječenih Velactisom (2,0%) u usporedbi sa životinjama liječenim placebom (10,7%).
English: cabergoline
Croatian: NUSPOJAVE
English: The recommended dose is 5.6 mg of cabergoline (corresponding to 5 ml of Velactis) per animal in one single injection at the day of drying-off after the last milking.
Croatian: Preporučena doza je 5,6 mg kabergolina (odgovara 5 ml Velactisa) po životinji u jednoj jednokratnoj injekciji na dan zasušivanja, nakon zadnje mužnje.
English: The difference between groups was 8.7% (95% confidence interval 4.9-12.6%).
Croatian: Razlika između skupina bila je 8,7% (95% interval pouzdanosti; 4,9-12,6%).
English: The product should only be used in dairy cows at the time of drying-off.
Croatian: Proizvod treba primjenjivati samo u muznih krava u vrijeme zasušivanja.
English: Disposal: read package leaflet
Croatian: Odlaganje: Pročitati uputu o VMP
English: This was confirmed in another multicentric randomized clinical trial where incidence of milk leakage was significantly lower among Velactis treated animals (3.9%) as compared to placebo treated animals (17.6%).
Croatian: To je potvrđeno u još jednom multicentričnom randomiziranom kliničkom ispitivanju u kojem je učestalost curenja mlijeka bila značajno niža u životinja liječenih Velactisom (3,9%) u usporedbi sa životinjama liječenim placebom (17,6%).
English: Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
Croatian: 6.6 Posebne mjere prilikom odlaganja neupotrebljenog veterinarsko-medicinskog proizvoda ili otpadnih materijala dobivenih primjenom tog proizvoda Bilo koji neupotrebljeni veterinarsko-medicinski proizvod ili otpadni materijali dobiveni primjenom tih veterinarsko-medicinskih proizvoda trebaju se odlagati u skladu s propisima o zbrinjavanju otpada.
English: Therefore, the product should only be administered to dairy cows at the time of drying-off.
Croatian: Zato proizvod treba primjenjivati samo u muznih krava u vrijeme zasušivanja.
English: The efficacy of Velactis in reducing the risk of new intramammary infections during the dry period when administered concomitantly with antimicrobial treatment to cows with intramammary infections has not been investigated compared to antimicrobial treatment alone.
Croatian: Djelotvornost primjene Velactisa zajedno s antimikrobnim liječenjem u usporedbi s primjenom samo antimikrobnog liječenja za smanjenje rizika od novih intramamarnih infekcija tijekom suhostaja kod krava s intramamarnim infekcijama nije istraživana.
English: In case of accidental self-injection, seek medical advice, and show this package leaflet or the label to the physician.
Croatian: U slučaju da se nehotice samoinjicira, potražite pomoć liječnika i pokažite mu ovu uputu o VMP ili etiketu.
English: CONTRAINDICATIONS Do not use in case of hypersensitivity to cabergoline or to any of the excipients.
Croatian: KONTRAINDIKACIJE Ne primjenjivati u slučaju preosjetljivosti na kabergolin ili na bilo koju od pomoćnih tvari.
English: Slight injection site reactions (mostly swellings) were commonly observed after injection of the product and may persist for at least 7 days.
Croatian: Nakon injiciranja lijeka često su zapažene blage reakcije na mjestu primjene (uglavnom oticanje) koje mogu potrajati najmanje 7 dana.
English: Cardboard box of 5 ml vial Cardboard box of 25 ml vial Cardboard box of 50 ml vial Cardboard box of 5x5 ml vials
Croatian: Kartonska kutija s bočicom od 5 ml Kartonska kutija s bočicom od 25 ml Kartonska kutija s bočicom od 50 ml Kartonska kutija s 5 bočica od 5 ml
English: The difference in percentage of new intramammary infections during the dry period between Velactis treated animals and the placebo group was 5.5% (95% confidence interval 0.5-10.4%).
Croatian: Razlika u postotku novih intramamarnih infekcija tijekom suhostaja između skupina životinja liječenih Velactisom i placebom bila je 5,5% (95% interval pouzdanosti; 0,5-10,4%).
English: However, administration of tylosin concomitantly with Velactis in cows did not show any changes of Velactis pharmacokinetic properties.
Croatian: Ipak, primjena tilozina zajedno s Velactisom nije pokazala nikakve promjene farmakokinetičkih svojstava Velactisa.
English: WITHDRAWAL PERIOD Withdrawal period: See box
Croatian: KARENCIJA Karencija: Vidjeti kutiju
English: Do not use in case of hypersensitivity to cabergoline or to any of the excipients.
Croatian: Ne primjenjivati u slučaju preosjetljivosti na kabergolin ili na bilo koju od pomoćnih tvari.
English: In case of accidental self-injection, seek medical advice, and show the package leaflet or the label to the physician.
Croatian: U slučaju da se nehotice samoinjicira, potražite pomoć liječnika i pokažite mu uputu o VMP ili etiketu.
English: However, administration of tylosin concomitantly with Velactis in cows did not show any changes of cabergoline pharmacokinetic properties.
Croatian: Ipak, primjena tilozina zajedno s Velactisom nije pokazala nikakve promjene farmakokinetičkih svojstava kabergolina.
English: Dimethyl sulfoxide Triglycerides, medium-chain
Croatian: 6.1 Popis pomoćnih tvari dimetilsulfoksid srednjelančani trigliceridi
English: METHOD AND ROUTE(S) OF ADMINISTRATION Intramuscular use
Croatian: NAČIN I PUT(EVI) PRIMJENE Intramuskularna primjena.
English: The difference in occurrence of pain was 9.9% (95% confidence interval 4-15.8%) between the Velactis treated cows compared to placebo treated animals.
Croatian: Razlika u pojavi boli bila je 9,9% (95% interval pouzdanosti; 4-15,8%) između krava liječenih Velactisom i životinja liječenih placebom.
English: STATEMENT OF ACTIVE AND OTHER SUBSTANCES 1 ml contains 1.12 mg of cabergoline.
Croatian: I DRUGIH TVARI 1 ml sadržava 1,12 mg kabergolina.
English: The difference in occurrence of pain was 9.9% (95% confidence interval 4.0-15.8%) between the Velactis treated cows compared to placebo treated animals.
Croatian: Razlika u pojavi boli bila je 9,9% (95% interval pouzdanosti; 4,0-15,8%) između krava liječenih Velactisom i životinja liječenih placebom.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Label of 5 ml vial
Croatian: OSNOVNI PODACI KOJI SE MORAJU NALAZITI NA MALIM UNUTARNJIM PAKOVANJIMA
English: For cows considered likely to be free of subclinical mastitis at drying off, in which antibiotic use is not justified/permitted, Velactis can be used as a dry cow treatment.
Croatian: Velactis se može primijeniti kao terapija za zasušivanje krava za koje se smatra da u vrijeme zasušivanja nemaju subklinički mastitis, u kojih primjena antibiotika nije opravdana/dopuštena.
English: Use during pregnancy, lactation or lay
Croatian: Primjena tijekom graviditeta, laktacije ili nesenja Može se primjenjivati tijekom graviditeta.
English: Label of 25 ml vial
Croatian: Etiketa za bočicu od 25 ml
English: Cabergoline Bovine 0.10 µg/kg 0.25 µg/kg
Croatian: 0,25 µg/kg 0,50 µg/kg 0,15 µg/kg 0,10 µg/kg masno tkivo jetra bubreg mišić mlijeko
English: Due to its pharmacological effect (inhibition of lactation) breastfeeding women should avoid contact with the product.
Croatian: Žene koje doje trebaju izbjegavati doticaj s proizvodom zbog njegovog farmakološkog djelovanja (inhibicije laktacije).
English: Label of 50 ml vial
Croatian: Etiketa za bočicu od 50 ml
English: NO ENTRY
Croatian: NEMA ZAPISA
English: PACKAGE LEAFLET FOR Velactis 1.12 mg/ml solution for injection for cattle.
Croatian: UPUTA O VMP ZA Velactis 1,12 mg/ml otopina za injekciju za goveda
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Velactis 1.12 mg/ml solution for injection for cattle
Croatian: NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Velactis 1,12 mg/ml otopina za injekciju za goveda
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Velactis 1.12 mg/ml solution for injection cabergoline
Croatian: NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Velactis 1,12 mg/ml otopina za injekciju kabergolin
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Velactis 1.12 mg/ml solution for injection for cattle (dairy cows).
Croatian: NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Velactis 1,12 mg/ml otopina za injekciju za goveda (muzne krave). kabergolin
English: The full EPAR for Emend can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Croatian: Cjeloviti EPAR za lijek Emend nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Emend on 11 November 2003.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za lijek Emend na snazi u Europskoj uniji od 11. studenoga 2003.
English: Emend is a neurokinin 1 (NK1) receptor antagonist.
Croatian: Emend je antagonist receptora neurokinina 1 (NK1).
English: • pimozide (used to treat mental illness);
Croatian: • pimozid (upotrebljava se za liječenje mentalnih bolesti);
English: Emend 80 mg and 125 mg must not be taken with the following medicines:
Croatian: Emend 80 i 125 mg ne smije se uzimati sa sljedećim lijekovima:
English: After chemotherapy, one 80 mg capsule is taken each day for the next two days.
Croatian: Nakon kemoterapije jedna kapsula od 80 mg uzima se svaki dan sljedeća dva dana.
English: In the chemotherapy studies in adults, adding Emend to the standard combination was more effective than the standard combination alone.
Croatian: U kemoterapijskim ispitivanjima provedenima među odraslima dodavanje lijeka Emend standardnoj kombinaciji bilo je učinkovitije od same standardne kombinacije.
English: • cisapride (used to relieve certain stomach problems).
Croatian: • cisaprid (koristi se za ublažavanje određenih želučanih problema).
English: In PONV, Emend was as effective as ondansetron.
Croatian: Kod PONV-a Emend je bio učinkovit kao i ondansetron.
English: Other information about Emend
Croatian: Ostale informacije o lijeku Emend
English: What measures are being taken to ensure the safe and effective use of Emend?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Emend?
English: This is nausea and vomiting that a patient can experience after surgery.
Croatian: Riječ je o mučnini i povraćanju koju bolesnik može iskusiti nakon operacije.
English: In PONV, two studies were carried out in a total of 1,727 adult patients, most of whom were women undergoing gynaecological operations.
Croatian: U pogledu PONV-a provedena su dva ispitivanja na ukupno 1 727 odraslih bolesnika, većinom žena koje su bile podvrgnute ginekološkim operacijama.
English: The dose of Emend oral suspension to be given depends on the patient's bodyweight.
Croatian: Doza oralne suspenzije Emend daje se ovisno o tjelesnoj težini bolesnika.
English: It stops a chemical in the body (substance P) from binding to the NK1 receptors.
Croatian: Sprečava vezanje kemijske tvari u tijelu (tvar P) na receptore NK1.
English: • terfenadine, astemizole (commonly used to treat allergy symptoms - these medicines may be available without a prescription);
Croatian: • terfenadin, astemizol (često se primjenjuju za liječenje alergijskih simptoma - ti se lijekovi mogu izdavati i bez liječničkog recepta);
English: Emend was also shown to be effective in the first 24 hours after chemotherapy.
Croatian: Emend se pokazao učinkovitim i u prva 24 sata nakon kemoterapije.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Emend.
Croatian: Objašnjava kako je Odbor za lijekove za humanu uporabu (CHMP) ocijenio lijek da bi donio svoje mišljenje u korist izdavanja odobrenja za stavljanje lijeka u promet te preporuke o uvjetima za primjenu lijeka Emend.
English: In children between 6 months and 12 years of age, Emend oral suspension is given together with a 5HT3 antagonist.
Croatian: U djece u dobi od 6 mjeseci do 12 godina oralna suspenzija Emend daje se zajedno s antagonistom 5HT3.
English: This is a summary of the European public assessment report (EPAR) for Emend.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Emend.
English: For more information about treatment with Emend, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Emend pročitajte u uputi o lijeku (također dio EPAR-a), ili se obratite svom liječniku ili ljekarniku.
English: Emend is a medicine containing the active substance aprepitant.
Croatian: Emend je lijek koji sadrži djelatnu tvar aprepitant.
English: Emend 40 mg capsules are used to prevent postoperative nausea and vomiting (PONV) in adults.
Croatian: Kapsule Emenda od 40 mg upotrebljavaju se za sprečavanje postoperativne mučnine i povraćanja (PONV) u odraslih.
English: Why has Emend been approved?
Croatian: Zašto je Emend odobren?
English: A risk management plan has been developed to ensure that Emend is used as safely as possible.
Croatian: Pripremljen je plan upravljanja rizikom kako bi se osigurala što sigurnija primjena lijeka Emend.
English: The most common side effect of Emend at all doses in adults (seen in between 1 and 10 patients in 100) is increased liver enzymes.
Croatian: Najčešće su nuspojave lijeka Emend pri svim dozama za odrasle (mogu se javiti u 1 do 10 bolesnika na 100) povišeni jetreni enzimi.
English: The first two studies involved a total of 1,094 adults receiving chemotherapy including cisplatin, and the third involved 866 adults with breast cancer who were receiving cyclophosphamide, with or without doxorubicin or epirubicin.
Croatian: U prva dva ispitivanja sudjelovalo je ukupno 1 094 odraslih koji su primali kemoterapiju uključujući cisplatin, a u trećemu je sudjelovalo 866 odraslih osoba koje boluju od raka dojke, a primali su ciklofosfamid, s doksorubicinom ili epirubicinom ili bez njih.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Emend, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana, u sažetku opisa svojstava lijeka kao i u uputi o lijeku za lijek Emend nalaze se sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: All three studies compared the effectiveness of Emend, taken in combination with dexamethasone and ondansetron, with that of the standard combination of dexamethasone and ondansetron.
Croatian: U sva tri ispitivanja uspoređivala se učinkovitost lijeka Emend, koji se uzima u kombinaciji s deksametazonom i ondansetronom, sa standardnom kombinacijom deksametazona i ondansetrona.